Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride effectively treat hair loss.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Dosing time affects finasteride's effectiveness and safety in rats.

Finasteride causes lasting fertility decrease in rats.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Hormonal therapies are safe and effective for treating adult women's acne.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.